Invest-CTO PCI Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Angina Pectoris
- Chronic Total Occlusion of Coronary Artery
- PROM
- Quality of Life
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Randomized, controlled, single-blinded, multicenter studyMasking: Double (Participant, Outcomes Assessor)Masking Description: Blinding of the participants to the index procedure in both arms. Blinding of invest group to 2nd procedure, and usual care group participants requiring an unplanned 2nd procedure. Corelabs and CEC will be blinded to treatment arm.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04774913
- Collaborators
- Golden Jubilee National Hospital
- Investigators
- Principal Investigator: Margaret B Mcentegart, PhD Golden Jubilee National Hospital Principal Investigator: Anja Øksnes, MD Haukeland University Hospital
Get Well Soon